184 related articles for article (PubMed ID: 8275461)
1. Activation of p53 gene expression in premalignant lesions during head and neck tumorigenesis.
Shin DM; Kim J; Ro JY; Hittelman J; Roth JA; Hong WK; Hittelman WN
Cancer Res; 1994 Jan; 54(2):321-6. PubMed ID: 8275461
[TBL] [Abstract][Full Text] [Related]
2. p53 protein accumulation and genomic instability in head and neck multistep tumorigenesis.
Shin DM; Charuruks N; Lippman SM; Lee JJ; Ro JY; Hong WK; Hittelman WN
Cancer Epidemiol Biomarkers Prev; 2001 Jun; 10(6):603-9. PubMed ID: 11401909
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of p53 protein is common in premalignant head and neck lesions.
Pavelic ZP; Li YQ; Stambrook PJ; McDonald JS; Munck-Wikland E; Pavelic K; Dacic S; Danilovic Z; Pavelic L; Mugge RE
Anticancer Res; 1994; 14(5B):2259-66. PubMed ID: 7840533
[TBL] [Abstract][Full Text] [Related]
4. p53 mutations and p53, Waf-1, Bax and Bcl-2 expression in field cancerization of the head and neck.
Lavieille JP; Gazzeri S; Riva C; Reyt E; Brambilla C; Brambilla E
Anticancer Res; 1998; 18(6B):4741-9. PubMed ID: 9891551
[TBL] [Abstract][Full Text] [Related]
5. Dysregulation of epidermal growth factor receptor expression in premalignant lesions during head and neck tumorigenesis.
Shin DM; Ro JY; Hong WK; Hittelman WN
Cancer Res; 1994 Jun; 54(12):3153-9. PubMed ID: 8205534
[TBL] [Abstract][Full Text] [Related]
6. Dominant negative p63 isoform expression in head and neck squamous cell carcinoma.
Sniezek JC; Matheny KE; Westfall MD; Pietenpol JA
Laryngoscope; 2004 Dec; 114(12):2063-72. PubMed ID: 15564824
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical study of p53 and angiogenesis in benign and preneoplastic oral lesions and oral squamous cell carcinoma.
Abbas NF; Labib El-Sharkawy S; Abbas EA; Abdel Monem El-Shaer M
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Mar; 103(3):385-90. PubMed ID: 17321451
[TBL] [Abstract][Full Text] [Related]
8. [The role of p53 tumor suppressor gene as prognostic factor in laryngeal squamous cell carcinoma].
Garozzo A; Cutrona D; Palmeri S; Maiolino L; Puzzo L; Allegra E
Acta Otorhinolaryngol Ital; 1999 Dec; 19(6):342-7. PubMed ID: 10875157
[TBL] [Abstract][Full Text] [Related]
9. Genetic instabilities of chromosome 9, 17 and accumulation of p53 overexpression during multistage tumorigesis in head and neck cancer.
Charuruks N; Shin DM; Voravud N; Ro JY; Hong WK; Hittelman WN
J Med Assoc Thai; 1996 Dec; 79 Suppl 1():S104-12. PubMed ID: 9071074
[TBL] [Abstract][Full Text] [Related]
10. Differential expressions of cyclin-dependent kinase inhibitors (p27 and p21) and their relation to p53 and Ki-67 in oral squamous tumorigenesis.
Choi HR; Tucker SA; Huang Z; Gillenwater AM; Luna MA; Batsakis JG; El-Naggar AK
Int J Oncol; 2003 Feb; 22(2):409-14. PubMed ID: 12527941
[TBL] [Abstract][Full Text] [Related]
11. P53 expression and polysomies of chromosome 9, 17 in head and neck cancer prognosis.
Charuruks N; Shin DM; Voravud N; Ro JY; Hong WK; Hittelman WN
J Med Assoc Thai; 1999 May; 82(5):466-76. PubMed ID: 10443096
[TBL] [Abstract][Full Text] [Related]
12. ras mutations and expression in head and neck squamous cell carcinomas.
Yarbrough WG; Shores C; Witsell DL; Weissler MC; Fidler ME; Gilmer TM
Laryngoscope; 1994 Nov; 104(11 Pt 1):1337-47. PubMed ID: 7968162
[TBL] [Abstract][Full Text] [Related]
13. Detection of survivin and p53 in human oral cancer: correlation with clinicopathologic findings.
Khan Z; Tiwari RP; Mulherkar R; Sah NK; Prasad GB; Shrivastava BR; Bisen PS
Head Neck; 2009 Aug; 31(8):1039-48. PubMed ID: 19340865
[TBL] [Abstract][Full Text] [Related]
14. Plasminogen activator inhibitor-2: a molecular biomarker for head and neck cancer progression.
Hasina R; Hulett K; Bicciato S; Di Bello C; Petruzzelli GJ; Lingen MW
Cancer Res; 2003 Feb; 63(3):555-9. PubMed ID: 12566295
[TBL] [Abstract][Full Text] [Related]
15. Field cancerisation and polyclonal p53 mutation in the upper aero-digestive tract.
Waridel F; Estreicher A; Bron L; Flaman JM; Fontolliet C; Monnier P; Frebourg T; Iggo R
Oncogene; 1997 Jan; 14(2):163-9. PubMed ID: 9010218
[TBL] [Abstract][Full Text] [Related]
16. Increased polysomies of chromosomes 7 and 17 during head and neck multistage tumorigenesis.
Voravud N; Shin DM; Ro JY; Lee JS; Hong WK; Hittelman WN
Cancer Res; 1993 Jun; 53(12):2874-83. PubMed ID: 8504429
[TBL] [Abstract][Full Text] [Related]
17. Expression of p53 in premalignant and malignant squamous epithelium.
Gusterson BA; Anbazhagan R; Warren W; Midgely C; Lane DP; O'Hare M; Stamps A; Carter R; Jayatilake H
Oncogene; 1991 Oct; 6(10):1785-9. PubMed ID: 1717923
[TBL] [Abstract][Full Text] [Related]
18. Expression of mutated p53 occurs in tumor-distant epithelia of head and neck cancer patients: a possible molecular basis for the development of multiple tumors.
Nees M; Homann N; Discher H; Andl T; Enders C; Herold-Mende C; Schuhmann A; Bosch FX
Cancer Res; 1993 Sep; 53(18):4189-96. PubMed ID: 8364914
[TBL] [Abstract][Full Text] [Related]
19. p53 expression above the basal cell layer in oral mucosa is an early event of malignant transformation and has predictive value for developing oral squamous cell carcinoma.
Cruz IB; Snijders PJ; Meijer CJ; Braakhuis BJ; Snow GB; Walboomers JM; van der Waal I
J Pathol; 1998 Apr; 184(4):360-8. PubMed ID: 9664901
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of nuclear retinoid receptors in normal, premalignant, and malignant head and neck tissues.
Xu XC; Ro JY; Lee JS; Shin DM; Hong WK; Lotan R
Cancer Res; 1994 Jul; 54(13):3580-7. PubMed ID: 8012985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
